Dicerna Pharmaceuticals Inc., of Lexington, Mass., appointed Stephen Doberstein to its board.
Enterprise Therapeutics Ltd., of Brighton, U.K., appointed David Morris chief medical officer.
Millendo Therapeutics Inc., of Ann Arbor, Mich., appointed Christophe Arbet-Engels chief medical officer.
Rexgenero Ltd., of London, appointed David Horn Solomon chair of its board.
Sellas Life Sciences Group Inc., of New York, appointed Dragan Cicic senior vice president, clinical development.
Trefoil Therapeutics Inc., of San Diego, appointed Thomas M. Tremblay vice president, clinical development.
Vectura Group plc, of Chippenham, U.K., appointed Sharon Johnson executive vice president for delivery management.